Acute hepatitis panel-696

Test info

  
Acute hepatitis panel
  
696
  
80074.0
  
AHP
  
  • Hepatitis A IgM
  • Hepatitis B surface antigen (HBsAg)
  • Hepatitis B Core IgM (HBC)
  • Hepatitis C Ab

 

  
  • If Li Heparin plasma is submitted and results are equivocal or reactive, confirmatory testing cannot be performed.
  • Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration.

Specimen

  
Serum
  
  
2.0 mL
  
0.5 mL
  

Immediatley following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  

Gold serum separator (SST) tube

  
Lithium heparin (Li hep) plasma
Sodium heparin (Na hep) plasma

If Heparin plasma is submitted and results are equivocal or reactive, confirmatory testing cannot be performed.
  

Immediately following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting

  

Lt green:

  1. Spin within two (2) hours of sample collection

Dk green:

  1. Spin
  2. Transfer plasma to a False bottom plasma/serum transport vial/tube (AHL), labelled as Na hep plasma, within two (2) hours of sample collection
  

Lt green plasma separator (PST)

False bottom plasma/serum transport vial/tube (AHL)

  

Refrigerated (preferred) - 7 days

Ambient - 3 days

Frozen - 3 months

  
  • Improper labels (unlabeled or mislabeled)
  • Hemolysis (some procedures)
  • Improper anticoagulant or ratio
  • Delay in transport
  • Improper storage temperature affecting results
  • Inappropriate timing of collection
  • Improper container
  • Leaking container resulting in compromised specimen
  • Quantity not sufficient (QNS)

Performance

  
AHL - Chemistry: C
  
Mo - Sa
  
1 day
  

Electrochemiluminescence immunoassay (ECLIA)

Clinical and Interpretive info

  

Non-reactive

Billing

  
80074
  
Yes
  

Tracking

  
11/30/2001
  
10/08/2024
  
01/11/2024